mTHPC-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: A multicenter study of 128 patients

Keyphrases

• Head-and-neck Cancer 100%
• Quality of Life 100%
• Photodynamic Therapy 100%
• Tumor Response 100%
• Clinical Quality 100%
• MTHPC 100%
• Tumor Mass 75%
• Mass Reduction 75%
• Head-and-neck 50%
• WHO Criteria 50%
• Complete Tumor Response 50%
• Tumor 25%
• Treatment Options 25%
• Squamous Cell Carcinoma of Head 25%
• Quality of Life Improvement 25%
• Patients with Advanced Cancer 25%
• Clinical Benefit 25%
• Laser Light 25%
• Clinical Improvement 25%
• Subset Analysis 25%
• Median Survival 25%
• University of Washington Quality of Life Questionnaire 25%
• Patient with Tumor 25%

Medicine and Dentistry

• Head and Neck Cancer 100%
• Neoplasm 100%
• Photochemotherapy 100%
• Temoporfin 100%
• Quality of Life 54%
• Neck 18%
• Squamous Cell Carcinoma 9%
• Advanced Cancer 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Photodynamic Therapy 100%
• Temoporfin 100%
• Neoplasm 100%
• Head and Neck Cancer 100%
• Squamous Cell Carcinoma 9%
• Advanced Cancer 9%